DOCSLIB.ORG

Effects of Direct Periaqueductal Grey Administration of a Cannabinoid Receptor Agonist on Nociceptive and Aversive Responses in Rats D.P

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Effects of Direct Periaqueductal Grey Administration of a Cannabinoid Receptor Agonist on Nociceptive and Aversive Responses in Rats D.P Provided by the author(s) and NUI Galway in accordance with publisher policies. Please cite the published version when available. Effects of direct periaqueductal grey administration of a Title cannabinoid receptor agonist on nociceptive and aversive responses in rats Finn, David P.; Jhaveri, M.D.; Jhaveri, Maulik D.; Beckett, Author(s) Simon Richard Graham; Roe, Clare H.; Kendall, David A.; Marsden, Charles Alexander; Chapman, Victoria Publication Date 2003-07-31 Finn, D. P., Jhaveri, M. D., Beckett, S. R. G., Roe, C. H., Kendall, D. A., Marsden, C. A., & Chapman, V. (2003). Publication Effects of direct periaqueductal grey administration of a Information cannabinoid receptor agonist on nociceptive and aversive responses in rats. Neuropharmacology, 45(5), 594-604. doi:https://doi.org/10.1016/S0028-3908(03)00235-1 Publisher Elsevier Link to publisher's https://doi.org/10.1016/S0028-3908(03)00235-1 version Item record http://hdl.handle.net/10379/16252 DOI http://dx.doi.org/10.1016/S0028-3908(03)00235-1 Downloaded 2021-09-25T11:27:31Z Some rights reserved. For more information, please see the item record link above. Neuropharmacology 45 (2003) 594–604 www.elsevier.com/locate/neuropharm Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats D.P. Finn ∗,1, M.D. Jhaveri 1, S.R.G. Beckett, C.H. Roe, D.A. Kendall, C.A. Marsden, V. Chapman Institute of Neuroscience, School of Biomedical Sciences, University of Nottingham, Queen’s Medical Centre, Nottingham NG7 2UH, UK Received 23 April 2003; accepted 23 May 2003 Abstract The analgesic potential of cannabinoids may be hampered by their ability to produce aversive emotion when administered sys- temically. We investigated the hypothesis that the midbrain periaqueductal grey (PAG) is a common substrate mediating the anti- nociceptive and potential aversive effects of cannabinoids. The rat formalin test was used to model nociceptive behaviour. Intra- PAG microinjection of the excitatory amino acid d,l-homocysteic acid (DLH) was used to induce an aversive, panic-like reaction characteristic of the defensive “fight or flight” response. Administration of the cannabinoid receptor agonist HU210 (5 µg/rat) into the dorsal PAG significantly reduced the second phase of formalin-evoked nociceptive behaviour, an effect which was blocked by µ co-administration of the CB1 receptor antagonist SR141716A (50 g/rat). This anti-nociceptive effect was accompanied by an HU210-induced attenuation of the formalin-evoked increase in Fos protein expression in the caudal lateral PAG. Intra-dorsal PAG administration of HU210 (0.1, 1 or 5 µg/rat) significantly reduced the aversive DLH-induced explosive locomotor response. The anti-nociceptive effect of HU210 is likely to result from activation of the descending inhibitory pain pathway. Mechanisms mediating the anti-aversive effects of cannabinoids in the PAG remain to be elucidated. These data implicate a role for the PAG in both cannabinoid-mediated anti-nociceptive and anti-aversive responses. 2003 Elsevier Ltd. All rights reserved. Keywords: Cannabinoid receptor; Pain; Periaqueductal grey; Aversion; Formalin test; Panic; c-Fos 1. Introduction (Jaggar et al., 1998). The finding that the anti-nocicep- tive effects of systemically administered cannabinoids The analgesic potential of cannabis and cannabinoids are reduced following disruption of the descending has long been recognised (Pertwee, 2001). However, inhibitory control pathway (Hohmann et al., 1999b) sup- cannabinoids induce aversive emotion and precipitate ports studies demonstrating that supraspinal sites of anxiety or panic attacks in about 22% of individuals action play a crucial role in the analgesia mediated by (Thomas, 1996). A greater understanding of the mech- systemically administered cannabinoids (Lichtman and anisms underlying cannabinoid-induced analgesia and Martin, 1991). aversion is needed if analgesic drugs without this Cannabinoid agonists are aversive in conditioned adverse side-effect profile are to be developed. place preference, taste avoidance and defensive with- Systemic administration of cannabinoids is anti- drawal paradigms (Parker and Gillies, 1995; McGregor nociceptive in the tail-flick test (Lichtman and Martin, et al., 1996a; De Fonseca et al., 1996; Sanudo-Pena et 1991) and in the formalin model of tonic, persistent pain al., 1997; Hutcheson et al., 1998; Cheer et al., 2000a). However, there is also some evidence for anti-aversive effects of cannabinoids in rat pup ultrasonic vocalisation ∗ Corresponding author. Tel.: +44-115-9709462; fax: +44-115- 9709259. (McGregor et al., 1996b) and light–dark box (Berrendero E-mail address: david.fi[email protected] (D.P. Finn). and Maldonado, 2002) paradigms. 1 Both authors contributed equally to this study. The midbrain periaqueductal grey (PAG) mediates 0028-3908/$ - see front matter 2003 Elsevier Ltd. All rights reserved. doi:10.1016/S0028-3908(03)00235-1 D.P. Finn et al. / Neuropharmacology 45 (2003) 594–604 595 behavioural responses to both aversive and nociceptive tal sinus, under isoflurane (1.5–2%) in nitrous oxide (1.5 stimuli (for review, see Bandler and Keay, 1996). The l/min)–oxygen (0.5 l/min) anaesthetic gas mixture. A PAG is an important component of the descending stylet made from stainless steel tubing (18 mm, 31 G) inhibitory pain control pathway (Wall and Melzack, was inserted into the guide cannula to prevent blockage 1999). PAG stimulation results in profound analgesia by debris. A non-steroidal anti-inflammatory agent, car- (Levine et al., 1991) which may occur with or without profen (4.5 mg kgϪ1, s.c., Rimadyl, Pfizer, UK), was aversive side-effects (Hosobuchi, 1983). Indeed Besson administered before the surgery for post-operative anal- et al. (1991) have suggested that anti-nociception gesia. Following cannula implantation, the rats were mediated by the dorsal PAG may be a consequence of housed singly. At least 6 days were allowed for recovery aversion. The defensive “fight or flight” response can be post-surgery. During this recovery period, the rats were induced in animals following chemical stimulation of the handled and their body weight and general health moni- PAG with excitatory amino acids such as d,l-homocys- tored once daily. teic acid (DLH) (Bandler, 1982; Beckett et al., 1992). CB1 receptors are present in moderate density and dis- 2.3. Microinjections tributed heterogeneously in the PAG (Herkenham et al., 1991; Tsou et al., 1998). Intra-PAG microinjection of Drugs or vehicle were microinjected manually into the cannabinoid agonists is anti-nociceptive in the rat tail- dorsal PAG (as defined by Bandler and Keay, 1996)in flick test (Lichtman et al., 1996). To date, the role of a volume of 250 nl or 500 nl over 60 s using an injector cannabinoid receptors in the PAG in modulation of and Hamilton syringe. These injection volumes were tonic, persistent pain behaviour or aversion has not selected on the basis of a large number of studies which been reported. have investigated the effects of direct microinjection of The aim of this study was to investigate the effect cannabinoids into discrete brain regions in models of of intra-dorsal PAG administration of the potent non- nociception including the tail-flick and formalin tests selective cannabinoid agonist HU210 on formalin- (Martin et al., 1998, 1999; Lichtman et al., 1996; Licht- evoked nociceptive behaviour, PAG Fos protein man and Martin, 1997; Monhemius et al., 2001). The expression and DLH-induced aversive behaviour in rats. injector comprised a stainless steel tube (31 G) with a We demonstrate for the first time that the PAG is a com- collar (23 G) sizing it to 20 mm (2 mm longer than the mon anatomical substrate mediating both cannabinoid- guide cannula) and an attached 1 m long polystyrene induced anti-nociceptive and anti-aversive responses. tube (0.75 mm OD, 0.28 mm ID) to allow injection of Some of this work has been published in abstract form the drug when the rat was placed in the arena. (Finn et al., 2001, 2002). 2.4. Effect of HU210 on formalin-induced nociceptive behaviour 2. Methods Each rat received HU210 (0.1, 1, 5 µg/250 nl) or 2.1. Animals dimethyl sulphoxide (DMSO, 60%) microinjection into the dorsal PAG followed 10 min later by formalin (50 Adult male Sprague-Dawley rats (250–300 g, Charles µl, 2.5% formaldehyde in 0.9% NaCl) or saline (0.9%) River, UK) were used for these experiments. One group injection into the sub-plantar region of the right hind of rats was used for the study of formalin-evoked behav- paw. Intra-plantar injections were carried out under brief iour and Fos expression, another group was used for isoflurane anaesthesia to minimise stress to the animals. determination of CB1 receptor involvement in the effects Behaviour was tracked for 10 min post-drug and 60 min observed and a separate group was used for the DLH- post-formalin in a transparent perspex box (30 × 30 × induced aversion study. Rats were group housed in cages 30 cm) and scored using Ethovision software by a of five prior to surgery. Food and water were available trained experimenter, blind to the treatments. The ad libitum and rats were housed on a 12 h light–dark maximum time taken to recover from anaesthesia, as cycle. All experiments were carried out in the light per- judged by regain of the righting reflex, was 2.5 min, and iod according to the UK Home Office Animals this initial period of the formalin trial was removed from (Scientific Procedures) Act 1986. the analysis. The video image was obtained from a cam- era positioned under the perspex box enabling clear 2.2. Cannula implantation examination of paw-directed behaviour throughout the experiment. In addition to rearing, grooming and dis- A stainless steel guide cannula (18 mm, 23 G) was tance moved, pain behaviours were scored according to stereotaxically implanted above the midbrain dorsal the weighted composite pain scoring technique (CPS- Ϫ + Ϫ PAG (AP 6.7, ML 1.7, DV 3.6, Paxinos and Wat- WST0,1,2) described by Watson et al.
Load more

Recommended publications
  • Identification of Discrete Functional Subregions of the Human
    Identification of discrete functional subregions of the human periaqueductal gray Ajay B. Satputea,1, Tor D. Wagerb, Julien Cohen-Adadc, Marta Bianciardid, Ji-Kyung Choid, Jason T. Buhlee, Lawrence L. Waldd, and Lisa Feldman Barretta,f aDepartment of Psychology, Northeastern University, Boston, MA, 02115; bDepartment of Psychology and Neuroscience, University of Colorado at Boulder, Boulder, CO 80309; cDepartment of Electrical Engineering, École Polytechnique de Montréal, Montreal, QC, Canada H3T 1J4; Departments of dRadiology and fPsychiatry, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129; and eDepartment of Psychology, Columbia University, New York, NY, 10027 Edited by Marcus E. Raichle, Washington University in St. Louis, St. Louis, MO, and approved September 9, 2013 (received for review March 30, 2013) The midbrain periaqueductal gray (PAG) region is organized into Unfortunately however, standard fMRI is fundamentally lim- distinct subregions that coordinate survival-related responses ited in its resolution, making it uncertain which fMRI results lie during threat and stress [Bandler R, Keay KA, Floyd N, Price J in the PAG and which lie in other nearby nuclei. The overarching (2000) Brain Res 53 (1):95–104]. To examine PAG function in humans, issue is size and shape. The PAG is small and is shaped like a researchers have relied primarily on functional MRI (fMRI), but tech- hollow cylinder with an external diameter of ∼6 mm, a height of nological and methodological limitations have prevented research- ∼10 mm, and an internal diameter of ∼2–3 mm. The cerebral ers from localizing responses to different PAG subregions.
    [Show full text]
  • The Role of Glutamatergic and Dopaminergic Neurons in the Periaqueductal Gray/Dorsal Raphe: Separating Analgesia and Anxiety
    The Role of Glutamatergic and Dopaminergic Neurons in the Periaqueductal Gray/Dorsal Raphe: Separating Analgesia and Anxiety The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Taylor, Norman E. "The Role of Glutamatergic and Dopaminergic Neurons in the Periaqueductal Gray/Dorsal Raphe: Separating Analgesia and Anxiety." eNeuro 6, 1 (January 2019): e0018-18.2019 © 2019 Taylor et al As Published http://dx.doi.org/10.1523/eneuro.0018-18.2019 Publisher Society for Neuroscience Version Final published version Citable link https://hdl.handle.net/1721.1/126481 Terms of Use Creative Commons Attribution 4.0 International license Detailed Terms https://creativecommons.org/licenses/by/4.0/ Confirmation Cognition and Behavior The Role of Glutamatergic and Dopaminergic Neurons in the Periaqueductal Gray/Dorsal Raphe: Separating Analgesia and Anxiety Norman E. Taylor,1 JunZhu Pei,2 Jie Zhang,1 Ksenia Y. Vlasov,2 Trevor Davis,3 Emma Taylor,4 Feng-Ju Weng,2 Christa J. Van Dort,5 Ken Solt,5 and Emery N. Brown5,6 https://doi.org/10.1523/ENEURO.0018-18.2019 1University of Utah, Salt Lake City 84112, UT, 2Massachusetts Institute of Technology, Cambridge 02139, MA, 3Brigham Young University, Provo 84602, UT, 4University of Massachusetts, Lowell 01854, MA, 5Massachusetts General Hospital, Boston 02114, MA, and 6Picower Institute for Learning and Memory, MIT, Cambridge, MA 02139 Abstract The periaqueductal gray (PAG) is a significant modulator of both analgesic and fear behaviors in both humans and rodents, but the underlying circuitry responsible for these two phenotypes is incompletely understood.
    [Show full text]
  • Neuronal and Glial Factors Contributing to Sex Differences in Opioid Modulation of Pain
    www.nature.com/npp NEUROPSYCHOPHARMACOLOGY REVIEWS Neuronal and glial factors contributing to sex differences in opioid modulation of pain Dayna L. Averitt 1, Lori N. Eidson2, Hillary H. Doyle3 and Anne Z. Murphy3 Morphine remains one of the most widely prescribed opioids for alleviation of persistent and/or severe pain; however, multiple preclinical and clinical studies report that morphine is less efficacious in females compared to males. Morphine primarily binds to the mu opioid receptor, a prototypical G-protein coupled receptor densely localized in the midbrain periaqueductal gray. Anatomical and physiological studies conducted in the 1960s identified the periaqueductal gray, and its descending projections to the rostral ventromedial medulla and spinal cord, as an essential descending inhibitory circuit mediating opioid-based analgesia. Remarkably, the majority of studies published over the following 30 years were conducted in males with the implicit assumption that the anatomical and physiological characteristics of this descending inhibitory circuit were comparable in females; not surprisingly, this is not the case. Several factors have since been identified as contributing to the dimorphic effects of opioids, including sex differences in the neuroanatomical and neurophysiological characteristics of the descending inhibitory circuit and its modulation by gonadal steroids. Recent data also implicate sex differences in opioid metabolism and neuroimmune signaling as additional contributing factors. Here we cohesively present these lines
    [Show full text]
  • Brain Structure and Function Related to Headache
    Review Cephalalgia 0(0) 1–26 ! International Headache Society 2018 Brain structure and function related Reprints and permissions: sagepub.co.uk/journalsPermissions.nav to headache: Brainstem structure and DOI: 10.1177/0333102418784698 function in headache journals.sagepub.com/home/cep Marta Vila-Pueyo1 , Jan Hoffmann2 , Marcela Romero-Reyes3 and Simon Akerman3 Abstract Objective: To review and discuss the literature relevant to the role of brainstem structure and function in headache. Background: Primary headache disorders, such as migraine and cluster headache, are considered disorders of the brain. As well as head-related pain, these headache disorders are also associated with other neurological symptoms, such as those related to sensory, homeostatic, autonomic, cognitive and affective processing that can all occur before, during or even after headache has ceased. Many imaging studies demonstrate activation in brainstem areas that appear specifically associated with headache disorders, especially migraine, which may be related to the mechanisms of many of these symptoms. This is further supported by preclinical studies, which demonstrate that modulation of specific brainstem nuclei alters sensory processing relevant to these symptoms, including headache, cranial autonomic responses and homeostatic mechanisms. Review focus: This review will specifically focus on the role of brainstem structures relevant to primary headaches, including medullary, pontine, and midbrain, and describe their functional role and how they relate to mechanisms
    [Show full text]
  • Medial Preoptic Area Afferents to Periaqueductal Gray Medullo- Output Neurons: a Combined Fos and Tract Tracing Study
    The Journal of Neuroscience, January 1, 1996, 16(1):333-344 Medial Preoptic Area Afferents to Periaqueductal Gray Medullo- Output Neurons: A Combined Fos and Tract Tracing Study Tilat A. Rimi,* Anne 2. Murphy,’ Matthew Ennis,’ Michael M. Behbehani,z and Michael T. Shipley’ ‘Department of Anatomy, University of Maryland School of Medicine, Baltimore, Maryland 21201, and *Departments of Cell Biology, Neurobiolog.v, and Anatomy and 3Molecular and Cellular Physiology, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 We have shown recently that the medial preoptic area (MPO) second series of experiments investigated whether MPO robustly innervates discrete columns along the rostrocaudal stimulation excited PAG neurons with descending projec- axis of the midbrain periaqueductal gray (PAG). However, the tions to the medulla. Retrograde labeling of PAG neurons location of PAG neurons responsive to MPO activation is not projecting to the medial and lateral regions of the rostroven- known. Anterograde tract tracing was used in combination with tral medulla (RVM) was combined with MPO-induced Fos Fos immunohistochemistry to characterize the MPO -+ PAG expression. The results showed that a substantial population pathway anatomically and ,functionally within the same animal. (3743%) of Fos-positive PAG neurons projected to the Focal electrical or chemical stimulation of MPO in anesthetized ventral medulla. This indicates that MPO stimulation en- rats induced extensive Fos expression within the PAG com- gages PAG-medullary output neurons. Taken together, these pared with sham controls. Fos-positive neurons were organized results suggest that the MPO + PAG + RVM projection as 2-3 longitudinal columns. The organization and location of constitutes a functional pathway.
    [Show full text]
  • Distinct Regions of the Periaqueductal Gray Are Involved in the Acquisition and Expression of Defensive Responses
    The Journal of Neuroscience, May 1, 1998, 18(9):3426–3432 Distinct Regions of the Periaqueductal Gray Are Involved in the Acquisition and Expression of Defensive Responses Beatrice M. De Oca, Joseph P. DeCola, Stephen Maren, and Michael S. Fanselow Department of Psychology, University of California, Los Angeles, Los Angeles, California 90024-1563 In fear conditioning, a rat is placed in a distinct environment and hanced, unconditional freezing to a cat. In experiment 2, lesions delivered footshock. The response to the footshock itself is of the dlPAG made before but not after training enhanced the called an activity burst and includes running, jumping, and amount of freezing shown to conditional fear cues acquired via vocalization. The fear conditioned to the distinct environment immediate footshock delivery. In experiment 3, vPAG lesions by the footshock elicits complete immobility termed freezing. made either before or after training with footshock decreased Lesions of the ventral periaqueductal gray (vPAG) strongly at- the level of freezing to conditional fear cues. Neither dlPAG tenuate freezing. However, lesions of the dorsolateral periaq- lesions nor vPAG lesions affected footshock sensitivity (exper- ueductal gray (dlPAG) increase the amount of freezing seen to iment 4) or consumption on a conditioned taste aversion test conditional fear cues acquired under conditions in which intact that does not elicit antipredator responses (experiment 5). On rats do not demonstrate much fear conditioning. To examine the basis of these results, it is proposed that activation of the the necessity of these regions in the acquisition and expression dlPAG produces inhibition of the vPAG and forebrain structures of fear, we performed five experiments that examined the ef- involved with defense.
    [Show full text]
  • A Neural Circuit for Competing Approach and Defense Underlying Prey Capture
    A neural circuit for competing approach and defense underlying prey capture Daniel Rossiera, Violetta La Francaa,b, Taddeo Salemia,c, Silvia Natalea,d, and Cornelius T. Grossa,1 aEpigenetics and Neurobiology Unit, European Molecular Biology Laboratory, 00015 Monterotondo (RM), Italy; bNeurobiology Master’s Program, Sapienza University of Rome, 00185 Rome, Italy; cDepartment of Biochemistry and Biophysics, Stockholm University, 10691 Stockholm, Sweden; and dDivision of Pharmacology, Department of Neuroscience, Reproductive and Odontostomatologic Sciences, School of Medicine, University of Naples Federico II, 80131 Naples, Italy Edited by Michael S. Fanselow, University of California, Los Angeles, CA, and accepted by Editorial Board Member Peter L. Strick February 11, 2021 (received for review July 22, 2020) Predators must frequently balance competing approach and defen- studies is their use of two different Cre driver lines (Vgat::Cre sive behaviors elicited by a moving and potentially dangerous prey. versus Gad2::Cre) that have been shown to target distinct LHA Several brain circuits supporting predation have recently been local- GABAergic neurons (23). Thus, it remains unclear to what extent ized. However, the mechanisms by which these circuits balance the different populations of LHA GABAergic neurons specifically en- conflict between approach and defense responses remain unknown. code and control predatory behaviors. Laboratory mice initially show alternating approach and defense A link between LHA and PAG in predation was made by
    [Show full text]
  • Pain-Relieving Mechanisms in Neuromodulation 10
    Pain-Relieving Mechanisms in Neuromodulation 10 Vikram Sengupta, Sascha Qian, Ned Urbiztondo, and Nameer Haider Introduction painful disease state being treated. Although clinical evi- dence will be provided, more exhaustive summaries of the Since its inception more than 50 years ago, the forms and clinical data will be reserved for later chapters in Part VI, applications of modern neuromodulation have undergone each of which is dedicated to the clinical aspects of a particu- tremendous expansion. The International Neuromodulation lar form of neuromodulation. Society defines neuromodulation as “the alteration of nerve activity through targeted delivery of a stimulus, such as elec- trical stimulation or chemical agents, to specific neurological Background and Historical Perspective sites in the body,” most commonly to reduce pain or improve neurologic function. All forms of neuromodulation are The earliest documented use of electrical current for the reversible. Neurostimulation is the most common form of treatment of pain was around 63 AD, when the Mesopotamian neuromodulation technology used today, and it refers to the physician, Scribonius Largus, discovered that shocks deliv- use of electrical or electromagnetic stimuli upon target tis- ered by the electrical torpedo fish could relieve bodily aches sues to elicit a therapeutic response. Although the focus of and pains. In the eleventh century, the Islamic philosopher this chapter will be on neurostimulation, other non-electrical Avicenna used cranial shocks delivered by the electric catfish therapies, such as intrathecal drug delivery systems, may fall to treat epilepsy. In the 1600s, the natural philosopher, into the category of neuromodulation. William Gilbert, reported using the magnetic lodestone to On August 10, 2017, the CDC recommended that the opi- treat headaches and psychiatric illness.
    [Show full text]
  • The Sensory Axis
    The sensory axis By Gustav Emil Dietrichson Things I’m going to cover and you’re going to understand • The basics • Cutaneous receptors • Dorsal column-medial lemniscus • Spinothalamic tract • The thalamus and the cortex • Pain • Quesons Receptors • Smulus à Conducon change à Generator poten?al • Intereceptors, exteroceptors, proprioceptors, teleceptors Thermoreceptors Chemoreceptors Photoreceptors Mechanoreceptors Nerve fibers • A • B – Preganglionic • C – Pain, temp • Aα – Propriocep?on autonomic ggl • 0,5-2m/s • 70-120m/s • 3-12m/s • Cggl – Postsynap?c • Aβ – Touch sympathe?ch ggl • 5-12m/s • 0,7-2,3m/s • Aγ – Motor • 3-6m/s • Aδ – Pain, temp • 12-30m/s A fibers = Thickest C fibers = Thinnest Cutaneous receptors • Merkel discs • Ruffini endings • Fine touch • Skin stretch • Discriminave touch Apical • Sustained pressure Basal • Meissner corpuscles • Pacinian corpuscles • Texture change • Deep touch • Slow vibraons • Fast vibraons • Both ”Corpuscles” are PHASIC receptors, while the other two are TONIC receptors • *ALL USE Aβ FIBERS Thalamus • What is the Thalamus? • Ventroposterolateral nucleusàBrodmann area 3,1,2 Dorsal column- medial lemniscus • Receives all informaon from • Merkel discs, Meissner corpuscles, Pacinian corpuscles, Ruffini endings • Muscles spindles and Golgi tendon organs • Propriocep?on • Fine touch • Vibraon (Low and high) • Pressure (deep and superficial) • Two touch discriminaon • DRAW! Spinothalamic tract Lateral spinothalamic tract • Anterior spinothalamic • Crude touch • Lateral spinothalamic • Temperature • Pain Everything
    [Show full text]
  • The Role of the Periaqueductal Gray Matter in Lower Urinary Tract Function
    Molecular Neurobiology https://doi.org/10.1007/s12035-018-1131-8 The Role of the Periaqueductal Gray Matter in Lower Urinary Tract Function Aryo Zare1,2 & Ali Jahanshahi2,3 & Mohammad-Sajjad Rahnama’i1 & Sandra Schipper1,2 & Gommert A. van Koeveringe1,2 Received: 3 October 2017 /Accepted: 14 May 2018 # The Author(s) 2018 Abstract The periaqueductal gray matter (PAG), as one of the mostly preserved evolutionary components of the brain, is an axial structure modulating various important functions of the organism, including autonomic, behavioral, pain, and micturition control. It has a critical role in urinary bladder physiology, with respect to storage and voiding of urine. The PAG has a columnar composition and has extensive connections with its cranially and caudally located components of the central nervous system (CNS). The PAG serves as the control tower of the detrusor and sphincter contractions. It serves as a bridge between the evolutionary higher decision-making brain centers and the lower centers responsible for reflexive micturition. Glutamatergic cells are the main operational neurons in the vlPAG, responsible for the reception and relay of the signals emerging from the bladder, to related brain centers. Functional imaging studies made it possible to clarify the activity of the PAG in voiding and filling phases of micturition, and its connections with various brain centers in living humans. The PAG may be affected in a wide spectrum of disorders, including multiple sclerosis (MS), migraine, stroke, Wernicke’s encephalopathy, and idiopathic normal pressure hydrocephalus, all of which may have voiding dysfunction or incontinence, in certain stages of the disease. This emphasizes the importance of this structure for the basic understanding of voiding and storage disorders and makes it a potential candidate for diagnostic and therapeutic interventions.
    [Show full text]
  • Sylvian Aqueduct Syndrome and Global Rostral Midbrain Dysfunction Associated with Shunt Malfunction
    Sylvian aqueduct syndrome and global rostral midbrain dysfunction associated with shunt malfunction Giuseppe Cinalli, M.D., Christian Sainte-Rose, M.D., Isabelle Simon, M.D., Guillaume Lot, M.D., and Spiros Sgouros, M.D. Department of Pediatric Neurosurgery and Pediatric Radiology, Hôpital Necker•Enfants Malades, Université René Decartes; and Department of Neurosurgery, Hôpital Lariboisiere, Paris, France Object. This study is a retrospective analysis of clinical data obtained in 28 patients affected by obstructive hydrocephalus who presented with signs of midbrain dysfunction during episodes of shunt malfunction. Methods. All patients presented with an upward gaze palsy, sometimes associated with other signs of oculomotor dysfunction. In seven cases the ocular signs remained isolated and resolved rapidly after shunt revision. In 21 cases the ocular signs were variably associated with other clinical manifestations such as pyramidal and extrapyramidal deficits, memory disturbances, mutism, or alterations in consciousness. Resolution of these symptoms after shunt revision was usually slow. In four cases a transient paradoxical aggravation was observed at the time of shunt revision. In 11 cases ventriculocisternostomy allowed resolution of the symptoms and withdrawal of the shunt. Simultaneous supratentorial and infratentorial intracranial pressure recordings performed in seven of the patients showed a pressure gradient between the supratentorial and infratentorial compartments with a higher supratentorial pressure before shunt revision. Inversion of this pressure gradient was observed after shunt revision and resolution of the gradient was observed in one case after third ventriculostomy. In six recent cases, a focal midbrain hyperintensity was evidenced on T2-weighted magnetic resonance imaging sequences at the time of shunt malfunction. This rapidly resolved after the patient underwent third ventriculostomy.
    [Show full text]
  • Pain Pathways (CN V, VII) Lab 8 March 26, 2021 - Dr
    Pain Pathways (CN V, VII) Lab 8 March 26, 2021 - Dr. Krebs ([email protected]) Objectives: 1. Apply the neuroanatomy of the facial nerve (CN VII) to common manifestations of facial palsy. 2. Apply the neuroanatomy of the trigeminal nerve (CN V) to common manifestations of trigeminal nerve lesions (trigeminal neuralgia). 3. Describe the pain pathways from the spinal cord through the brainstem to the cortex, and their integration with the modulation of the pain experience. 4. Integrate peripheral nociception with the central experience and modulation of the pain experience. Use today’s lab to review all of your neuroanatomy from previous labs. Make sure you take advantage of looking at all of the specimens we have studied over the past term. ** NOTE: Interactive PDFs are best viewed on desktop/laptop computers - functionality is not reliable on mobile devices ** Design & Artwork: The HIVE (hive.med.ubc.ca) 1 Pain Pathways (CN V, VII) Lab 8 March 26, 2021 - Dr. Krebs ([email protected]) Facial Nerve (CN VII) Identify CN VII on gross specimens Modality Associated Nucleus Function Motor Facial nucleus Motor to muscles of facial expression (SVE) Parasympathetic Parasympathetic innervation to lacrimal, Superior salivatory nucleus (GVE) submandibular & sublingual glands Somatic Sensory Chief sensory nucleus of V General sensation from outer ear (GSA) Spinal nucleus and tract of V Taste Solitary nucleus and tract Taste from anterior 2/3 of tongue (SVA) In addition to their location, you also need to know the function and the consequences of a lesion to the nuclei. Design & Artwork: The HIVE (hive.med.ubc.ca) 2 Pain Pathways (CN V, VII) Lab 8 March 26, 2021 - Dr.
    [Show full text]